AbbVie to Present at the 43rd Annual J.P. Morgan Healthcare Conference
AbbVie (ABBV) has announced its upcoming participation in the 43rd Annual J.P.
Rhea-AI Summary
AbbVie (ABBV) has announced its upcoming participation in the 43rd Annual J.P. Morgan Healthcare Conference. The company's management will engage in a fireside chat on Wednesday, January 15, 2025, at 10:15 a.m. Central time.
Investors and interested parties can access a live audio webcast of the presentation through AbbVie's Investor Relations website at investors.abbvie.com. For those unable to attend the live session, an archived version will be made available later the same day.
Positive
- None.
Negative
- None.
Details
News Market Reaction – ABBV
The recorded move for ABBV in the trading session of this news was -1.87%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302346551.html
SOURCE AbbVie
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
